Relationship between CD4+CD25+ Treg and expression of HIF-1α and Ki-67 in NSCLC patients

European Review for Medical and Pharmacological Sciences

Volumn 19, Issue 8, 2015, Pages 1351-1355

  He, L Y ^a   Li, L ^a   Guo, M L ^a   Zhang, Y ^a   Zhang, H Z ^a  

^a HEBEI GENERAL HOSPITAL   (China)

Author keywords

CD4+CD25+ regulatory T lymphocyte; Hypoxia inducing Factor 1 ; Ki 67; Non smallcell lung carcinoma biology

Indexed keywords

CD4 ANTIGEN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INTERLEUKIN 2 RECEPTOR ALPHA; KI 67 ANTIGEN; HIF1A PROTEIN, HUMAN; IL2RA PROTEIN, HUMAN; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER PROGNOSIS; CANCER TISSUE; CD4+ CD25+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOCOMPETENT CELL; IMMUNOHISTOCHEMISTRY; MALE; NON SMALL CELL LUNG CANCER; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; TUMOR IMMUNITY; BIOSYNTHESIS; CARCINOMA, NON-SMALL-CELL LUNG; CD4+ T LYMPHOCYTE; GENE EXPRESSION REGULATION; IMMUNOLOGY; LUNG TUMOR; METABOLISM; MIDDLE AGED;

ADULT; AGED; BIOMARKERS, TUMOR; CARCINOMA, NON-SMALL-CELL LUNG; CD4-POSITIVE T-LYMPHOCYTES; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; KI-67 ANTIGEN; LUNG NEOPLASMS; MALE; MIDDLE AGED; T-LYMPHOCYTES, REGULATORY;

EID: 84942242209     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. JUSUFOVIC E, ILJAZOVIC E, KOSNIK M, KESER D, KOROSEC P, ZUKIC E, PRNJAVORAC B, SEJDINOVI R, AJANOVI E. Local D4+, CD8+ and CD56+ reactions to lung cancer in regard to pathohistological type and clinical stage. Medicinski Glasnik 2011; 8: 101-108.
2. MA GF, ZHANG RF, YING KJ, WANG D. Effect evaluation of cisplatin-gemcitabine combination chemotherapy for advanced non-small cell lung cancer patients using microarray data. Eur Rev Med Pharmacol Sci 2015; 19: 578-585.
3. ZHANG B, LIU ZM, HAO FG, WANG M. siRNA-directed clusterin silencing promotes cisplatin antitumor activity in human non-small cell lung cancer xenografts in immunodeficient mice. Eur Rev Med Pharmacol Sci 2014; 18: 1595-1601.
4. LI J, SHI R, YU P. Effects of chemotherapy on global gene expression in non-small cell lung cancer. Eur Rev Med Pharmacol Sci 2014; 18: 126-131.
5. RUFFINI E, ASIOLI S, FILOSSO PL, LYBERIS P, BRUNA MC, MACRÌ L, DANIELE L, OLIARO A. Clinical significance of tumor-infiltrating lympocytes in lung neoplasms. Ann Thorac Surg 2009; 87: 365-372.
6. LV Y, SHEN Y, HUANG J. Analysis of the peripheral blood lymphocyte subsets and their correlation with the clinical properties of lung cancer patients. J Clin Pulmon Med 2011; 9: 1420-1422.
7. QIN J, TENG J, FENG G. Changes of regulatory T lymphocyte level in peripheral blood of nasopharyngeal patients. Pract Oncol 2010; 4: 416-418.
8. JU S, QIU H, ZHOU X, ZHU B, LV X, HUANG X, LI J, ZHANG Y, LIU L, GE Y, JOHNSON DE, JU S, SHU Y. CD13+CD4+CD25hi regulatory T cells exhibit higher suppressive function and increase with tumor stage in non-small cell lung cancer patients. Cell Cycle 2009; 8: 2578-2585.
9. ZHANG W, ZHANG H, XING L. Antisense oligonucleotide of hypoxia-inducible factor-1alpha suppresses growth and tumorigenicity of lung cancer cells A549. J Huazhong Univ Sci Technolog Med Sci 2006; 26: 448-450.
10. KURATOMI K, YANO H, TSUNEOKA M, SAKAMOTO K, KUSUKAWA J, KOJIRO M. Immunoohistochemical expression of mina53 and ki-67 proteins in human primary gingival squamous cell c-arcinoma. Kurume Med J 2006; 53: 71-78.
11. GENTITE V, VICLNI P, GLACOMELLII, CARDILLO MR, PIERANGELI A, DEGENER AM. Detection of human papillomavirus DNA, p53 and ki-67 expression penile carcinomas. Int J Immunopathol Pharmacol 2006; 19: 209-215.